Bluebee provides a cloud-based genomics analysis solution combined with accelerated hardware to enable fast and efficient processing of large volumes of genomics data. Its technology aims to reduce complexity and throughput time for research centres, clinical labs and diagnostics companies. The company was founded in 2011 by Prof. dr. ir. Koen Bertels as a spin-off of Delft University of Technology and Imperial College London and is led by CEO Hans Cobben. Bluebee is based in Delft, The Netherlands. It raised €10M in Series A funding and intends to use the proceeds to innovate the Bluebee platform. The financing supports continued product development and scaling of its cloud high-performance genomics solutions. Bluebee provides a cloud-based, distributed computing platform combined with accelerated hardware to process large sequencing data volumes in very short timeframes. The platform has been piloted by Tier 1 clinical research labs such as DKFZ (German Cancer Research Center). Bluebee was founded in 2011 as a spin-off of Delft University of Technology and Imperial College London and is led by CEO Hans Cobben. The company is based in Delft, The Netherlands. It offers a genomics solution aimed at clinicians and labs and intends to expand adoption in those markets. Bluebee raised external funding to support that go-to-market effort.

Total raised

$13M

Funding rounds

2

Latest round

Series A

Latest activity

Apr 2016